Director, Supply Chain at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalIndustries

Requirements

  • 12+ years of relevant experience in related field and a BS or BA; or 10+ years of relevant experience and a MA/MBA
  • Expert working knowledge of clinical supply chain best practices
  • Experience working in a GxP environment
  • Strong cross-functional, multi-cultural awareness and communication skills
  • Able to develop complex concepts

Responsibilities

  • Serves as the clinical supply lead on PDM sub-teams especially for complex development programs (e.g., late phase, acquisition, partnership/alliance, new modality, etc.)
  • Leads the development and execution of overall clinical supply strategy and management for clinical development program(s), including management of investigational medicinal product (IMP) for assigned global trials
  • Oversees and supports clinical study planners in a matrix environment; facilitates issue and risk identification, mitigation, resolution and communication
  • Drives decision-making at cross-functional teams (ClinOps, PDM sub-teams) supporting the long-term vision
  • Identifies, manages and mitigates supply risks at clinical development program level
  • Leads and drives visible, impactful process improvements, change business and organizational imperatives
  • Authors, revises and reviews standard operating procedures (SOPs), work instructions and business policies
  • Accountable for clinical supply budget of assigned clinical development program(s)
  • Reviews and approves statement of work, purchase orders and invoices
  • Influences, at times drives, program allocations at partners, contract manufacturing organizations (CMOs)
  • Leads or contributes to GCSC, GSC or PDM strategic initiatives including due diligence resource pool, global drug delivery community, clinical supply integration due to M&A and policy topic member supporting the External Advocacy Steering Team (EAST)

Skills

Supply Chain Planning
Clinical Supply Chain
Inventory Management
Manufacturing Planning
Distribution Management
Protocol Design
Regulatory Compliance
Project Management
Quality Assurance
Global Supply Chain

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI